reapproval

Reapproval is the act of granting formal approval again after previous approval has lapsed, been revoked, or required updating. It involves re-evaluation of evidence, compliance status, and current standards to determine whether the subject continues to meet requirements.

In regulatory contexts, reapproval is common for medicines, medical devices, and other products when new data, safety concerns, or changes in indications arise. Regulators may require updated clinical data, post-market surveillance, or reaffirmation of risk–benefit balance before renewing or extending authorization.

In licensing and credentialing, individuals and organizations may undergo reapproval or renewal to maintain authorization to operate. Requirements typically include continuing education, credentials verification, fee payment, and proof of ongoing competence or compliance with professional standards.

In policy and program management, reapproval can occur when programs receive continuation authority, new funding, or updated terms of grant or statute. Reapproval reviews assess performance, outcomes, and alignment with public goals, and may adjust scope, funding, or conditions.

Procedures for reapproval vary by jurisdiction and domain, but common elements include submission of evidence, formal review by an approving body, possible conditions or probation, and opportunities for appeal or comment. The term is related to, but not always interchangeable with, renewal, reauthorization, or recertification.